Evaluation of Serum Follistatin-Like Protein 1 Levels in Behcet's Disease and Its Association Wit… (NCT06730958) | Clinical Trial Compass
CompletedNot Applicable
Evaluation of Serum Follistatin-Like Protein 1 Levels in Behcet's Disease and Its Association With Disease Activity
Egypt80 participantsStarted 2024-01-01
Plain-language summary
Behçet's disease (BD) is a multi-system auto inflammatory disorder with vasculitic features.
The exact etiological of BD is still obscure, although environmental and genetics factors have been found to be involved in disease pathogenesis.FSTL-1 can act as diagnostic and prognostic biomarkers for Some inflammatory autoimmune diseases including BD.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adult BD patients who fulfilling the criteria for the diagnosis by International Team for the Revision of the International Criteria for Bechet's Disease
Exclusion Criteria:
* Individuals with other autoimmune diseases (rheumatoid arthritis dermatomyositis, scleroderma, mixed connective tissue disease).
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This study measured a protein called FSTL1 in the blood of people with Behcet's disease — can you explain what FSTL1 is and why researchers think it might be connected to how active Behcet's disease is?
2Since this trial is already completed, have the results been published anywhere, and if so, what did they find about whether FSTL1 levels actually tracked with disease flares or activity?
3If FSTL1 turns out to be a reliable marker of disease activity, how might that change the way my Behcet's disease is monitored or managed in the future?
4This was an observational study measuring a blood protein rather than testing a treatment — does that mean there's no new therapy being offered here, and what are the current standard treatment options I should be considering right now?
5Are there other biomarker studies or clinical trials for Behcet's disease that might be relevant to my situation that I should know about alongside this one?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.